Ana Martinez-Naharro

7PUBLICATIONS
49CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Gene and molecular therapyInstrumental methods (excl. immunological and bioassay methods)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 12, 2026
Diagnosis of Cardiac Amyloidosis on Echocardiography Using Artificial Intelligence.

Adam Ioannou, Michel G Khouri, Takeshi Kitai

|Feb 02, 2026
Efficacy of Suppression of Serum Transthyretin With Patisiran and Vutrisiran in Variant ATTR Amyloidosis: An Observational Crossover Study.

Yousuf Razvi, Muhammad Umaid Rauf, Aldostefano Porcari

|Jan 09, 2024
Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis.

Joshua Bomsztyk, Sriram Ravichandran, Hannah V Giles

|Oct 14, 2022
Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment.

Ana Martinez-Naharro, Rishi Patel, Tushar Kotecha

|May 24, 2022
Characteristics and natural history of early-stage cardiac transthyretin amyloidosis.

Steven Law, Melanie Bezard, Aviva Petrie

|Sep 02, 2021
Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis.

Oliver C Cohen, Andreia Ismael, Babita Pawarova

Pageof 2

Frequent Collaborators

5 joint publications

Philip N Hawkins

5 joint publications

Julian D Gillmore

4 joint publications

Marianna Fontana

3 joint publications

Muhammad Umaid Rauf